Monotherapy anticoagulation to expedite home treatment of venous thromboembolism (MATH VTE) Save

Date Added
May 21st, 2019
PRO Number
Pro00085403
Researcher
Andrew Matuskowitz

List of Studies


Profiles_link
Keywords
Blood Disorders
Summary

Previous studies have shown that many patients diagnosed with blood clots in the lungs and limbs can be safely discharged home from the emergency department with blood thinner therapy. However, physician discomfort and prescription medication cost results in many patients being admitted to the hospital. This study aims to show that the majority of low risk patients with blood clots who are started on a blood thinner called apixaban can be safely discharged from the emergency department without having a bad outcome. Specifically, we expect to find that these patients have a very low risk of worsening blood clot or bleeding within the first month after starting apixaban.

Institution
MUSC
Recruitment Contact
Aja Bayo
843-792-7944
bayo@musc.edu

Change_preferences

-- OR --

Create_login